LYON, France--(BUSINESS WIRE)--The MEDICREA Group (FR0004178572-ALMED) (Paris:ALMED) listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal disorders, is publishing its 2011 half year results.
